Zhimin Hu

1.6k citations
36 papers · 918 indexed · h-index 14
Topics
Liver Disease Diagnosis and Treatment (5 papers)Berberine and alkaloids research (4 papers)Tissue Engineering and Regenerative Medicine (3 papers)
Partner nations
ChinaUnited StatesSweden

In The Last Decade

Zhimin Hu

34 papers receiving 902 citations

Peers

Zhimin Hu
Comparison fields: 5 of 96
  • Molecular Biology 411
  • Epidemiology 205
  • Surgery 189
  • Genetics 168
  • Physiology 126
Replace Tommaso Scolaro with:
Tommaso Scolaro Belgium
Peng Zhao China
Nancy Cheng United States
Yi Rang Na South Korea
Soonjae Hwang South Korea
Qingqing Li China
Chen‐Hao Yeh United States
Hongbo Xu China
Min Fang China
Xufei Zhang China
Zhimin Hu relative to Tommaso Scolaro Belgium Tommaso Scolaro's profile →
Citations per field
00.5×11.3×
Tommaso Scolaro · 1×
Citations per year

Countries citing papers authored by Zhimin Hu

Since Specialization
Citations

This map shows the geographic impact of Zhimin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhimin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhimin Hu more than expected).

Fields of papers citing papers by Zhimin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhimin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhimin Hu. The network helps show where Zhimin Hu may publish in the future.

Co-authorship network of co-authors of Zhimin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhimin Hu. A scholar is included among the top collaborators of Zhimin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhimin Hu. Zhimin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 5
3 2
4 4
5 3
6 15
7 12
8 5
9 8
10 115
11 251
12 12
13 71
14 13
15 10
16
Marchantin M displays growth inhibitory effects on human prostate cancer cells
1
17 32
18 43
19 15
20
A case report of primary cutaneous mucormycosis caused by Rhizomucor variabilis
3

About Zhimin Hu

Zhimin Hu is a scholar working on Molecular Medicine, Epidemiology and Pharmacology, having authored 36 papers that have together received 918 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Berberine and alkaloids research (4 papers) and Tissue Engineering and Regenerative Medicine (3 papers). The work is most often cited by research in Biological Psychiatry (44 citations), Genetics (168 citations) and Hepatology (76 citations). Zhimin Hu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Guosheng Lin, Cuiyu Bao, Jun Guo, Yu Li, Aoyuan Cui, Yamei Han, Fengguang Ma, Yaqian Xue, Jing Gao and Zhengshuai Liu. Their work appears in journals such as Nature Communications, Hepatology and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026